Hanson & Doremus Investment Management held its stake in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,435 shares of the financial services provider’s stock at the end of the second quarter. Hanson & Doremus Investment Management’s holdings in CME Group were worth $555,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Chevy Chase Trust Holdings Inc. increased its stake in shares of CME Group by 5.7% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 585,946 shares of the financial services provider’s stock valued at $69,610,000 after buying an additional 31,769 shares during the period. Burns J W & Co. Inc. NY increased its stake in shares of CME Group by 6.1% in the first quarter. Burns J W & Co. Inc. NY now owns 17,361 shares of the financial services provider’s stock valued at $2,062,000 after buying an additional 997 shares during the period. New England Research & Management Inc. acquired a new position in CME Group during the first quarter worth approximately $368,000. Raymond James Trust N.A. increased its position in CME Group by 4.7% in the first quarter. Raymond James Trust N.A. now owns 13,972 shares of the financial services provider’s stock worth $1,660,000 after buying an additional 631 shares during the last quarter. Finally, National Pension Service increased its position in CME Group by 6.3% in the first quarter. National Pension Service now owns 254,243 shares of the financial services provider’s stock worth $30,217,000 after buying an additional 15,099 shares during the last quarter. Institutional investors own 83.25% of the company’s stock.
CME Group Inc. (NASDAQ:CME) traded up 0.02% during mid-day trading on Friday, reaching $125.39. The company’s stock had a trading volume of 1,048,291 shares. The firm has a 50-day moving average of $123.50 and a 200-day moving average of $121.16. The stock has a market capitalization of $42.62 billion, a price-to-earnings ratio of 25.60 and a beta of 0.73. CME Group Inc. has a 52 week low of $98.95 and a 52 week high of $127.96.
CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The company had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business’s revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.14 earnings per share. On average, equities research analysts expect that CME Group Inc. will post $4.80 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 53.99%.
A number of research firms have recently commented on CME. Royal Bank Of Canada increased their price objective on CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Tuesday, June 20th. Deutsche Bank AG dropped their price objective on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Friday. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $127.00 price objective on shares of CME Group in a report on Friday. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $128.00 price objective on shares of CME Group in a report on Monday, July 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company’s stock. CME Group presently has a consensus rating of “Buy” and an average target price of $131.63.
In other news, insider Kathleen M. Cronin sold 8,125 shares of the business’s stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $127.35, for a total transaction of $1,034,718.75. Following the completion of the transaction, the insider now directly owns 38,174 shares in the company, valued at $4,861,458.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Sunil Cutinho sold 10,265 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total value of $1,209,730.25. Following the transaction, the insider now owns 21,690 shares of the company’s stock, valued at $2,556,166.50. The disclosure for this sale can be found here. Insiders have sold 91,085 shares of company stock valued at $11,242,896 over the last ninety days. Corporate insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.